Frontiers in Bioengineering and Biotechnology (Sep 2022)

Microbiome engineering: engineered live biotherapeutic products for treating human disease

  • Jack W. Rutter,
  • Linda Dekker ,
  • Kimberley A. Owen ,
  • Chris P. Barnes ,
  • Chris P. Barnes 

DOI
https://doi.org/10.3389/fbioe.2022.1000873
Journal volume & issue
Vol. 10

Abstract

Read online

The human microbiota is implicated in many disease states, including neurological disorders, cancer, and inflammatory diseases. This potentially huge impact on human health has prompted the development of microbiome engineering methods, which attempt to adapt the composition and function of the human host-microbiota system for a therapeutic purpose. One promising method is the use of engineered microorganisms that have been modified to perform a therapeutic function. The majority of these products have only been demonstrated in laboratory models; however, in recent years more concepts have reached the translational stage. This has led to an increase in the number of clinical trials, which are designed to assess the safety and efficacy of these treatments in humans. Within this review, we highlight the progress of some of these microbiome engineering clinical studies, with a focus on engineered live biotherapeutic products.

Keywords